Solid-lipid nanoparticles as a novel technology for delivering minocycline to the ischaemic brain
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Presentation
- By: WALKER, Roderick (Rhodes University, South Africa)
- Co-author(s): Janeeta Ranchhod: Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa
Roderick Bryan Walker: Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa
Minocyline exhibits anti-inflammatory, anti-apoptotic and neuroprotective activity unrelated to its antibiotic properties making it a candidate for treating stroke . Nanotechnology has yielded encouraging results for delivery of drugs to the CNS.
Design of Experiments (DoE) and Response Surface Methodology (RSM) was used.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.